Alona Crowder, PharmD, Aniket Sidhaye, M.D.
Bromocriptine is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --



  • Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
  • Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease


  • Neuroleptic malignant syndrome

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 2, 2019